Thurston Springer Miller Herd & Titak’s NeoGenomics NEO Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300	Closed	-$2.19K	–	1072
2025 Q2	$2.19K	Hold	300	–	–	﹤0.01%	1406
2025 Q1	$2.85K	Hold	300	–	–	﹤0.01%	1390
2024 Q4	$4.94K	Hold	300	–	–	﹤0.01%	1016
2024 Q3	$4.42K	Hold	300	–	–	﹤0.01%	1222
2024 Q2	$4.16K	Buy	+300	New	+$4.25K	﹤0.01%	1209

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's NEO Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 300 shares — an estimated $2.19K sold.

Thurston Springer Miller Herd & Titak first reported a position in NEO in Q2 2024 and held it in 5 quarters. The position peaked at $4.94K in Q4 2024. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

Thurston Springer Miller Herd & Titak reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
Thurston Springer Miller Herd & Titak sold 300 NeoGenomics shares in Q3 2025, an estimated $2.19K.
Thurston Springer Miller Herd & Titak first reported a position in NeoGenomics in Q2 2024 and held it in 5 quarters.
Thurston Springer Miller Herd & Titak's NeoGenomics position peaked at $4.94K in Q4 2024.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.